Boerhavia diffusa is a renowned edible medicinal plant extensively used against different ailments including heart diseases in the traditional system of medicine in several countries. The present study aims to evaluate the therapeutic efficacy of ethanolic extract of Boerhavia diffusa (BDE) on cardiac hypertrophy and fibrosis induced by angiotensin II (Ang II) in male wistar rats and to identify the active components present in it. A substantial increase of hypertrophy markers such as cardiac mass index, concentration of ANP and BNP, cardiac injury markers like CK-MB, LDH and SGOT, has been observed in hypertrophied groups whereas BDE treatment attenuated these changes when compared to hypertrophied rats. Moreover, Ang II induced myocardial oxidative stress was reduced by BDE which was apparent from diminished level of lipid and protein oxidation products, increased activities of membrane bound ATPases and endogenous antioxidant enzymes along with enhanced translocation of Nrf2 from the cytosol to nucleus. It appears that BDE evokes its antioxidant effects by attenuating lipid peroxidation, enhancing the translocation of Nrf2 from the cytoplasm to nucleus as well as by regulating the metabolism of glutathione. The extent of fibrosis during cardiac hypertrophy was determined by histopathology analysis and the results revealed that BDE treatment considerably reduced the fibrosis in the heart. HPLC analysis of BDE leads to the identification of four compounds viz., quercetin, kaempferol, boeravinone B and caffeic acid. The study substantiate the effect of B. diffusa in protecting the heart from pathological hypertrophy and the attenuation of cardiac abnormalities may be partly attributed through the reduction of oxidative stress and cardiac fibrosis. Since the plant is widely used as a green leafy vegetable, incorporation of this plant in diet may be an alternative way for the prevention and better management of heart diseases and associated complications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.biopha.2016.12.114 | DOI Listing |
Pharmaceutics
December 2024
Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia.
Angiotensin-converting enzyme (ACE) is a key regulator of blood pressure, and ACE inhibition is an essential part of the treatment of hypertension. We used a molecular docking approach to find the interaction of ACE with an active flavonoid isolated from Linn, , which leads to potential antihypertensive effects in methyl predenisolone-induced hypertensive rats. Additionally, the pharmacokinetic parameters of this compound are assessed.
View Article and Find Full Text PDFJ Biomol Struct Dyn
November 2024
School of Biotechnology, Centurion University of Technology and Management (CUTM), Bhubaneswar, India.
Front Chem
November 2024
School of Pharmacy, Faculty Medical Division, Macau University of Science and Technology, Macau, China.
Spectrochim Acta A Mol Biomol Spectrosc
January 2025
Department of Chemistry & Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh 160014, India. Electronic address:
In view of exploiting natural resources for designing of effectual materials in favor of detection and obliteration of water pollutants, a fluorescent nanomaterial (CDBHCF) based on biomass derived carbon dots (CDs) was constructed. The CDs and cobalt ferrite (CF) particles were anchored on boehmite (BH) which served as a support material for CDs. The CDBHCF nanocomposite was prepared via facile hydrothermal treatment for selective recognition of Methyl parathion (MP) pesticide and uranyl ions (UO).
View Article and Find Full Text PDFAssay Drug Dev Technol
October 2024
Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!